Upcoming Stock Splits This Week (September 2 to September 6) – Stay Invested [Yahoo! Finance]
ARCA biopharma, Inc. (ABIO)
US:NASDAQ Investor Relations:
arcabio.com/investors
Company Research
Source: Yahoo! Finance
corporate action in which the company issues additional common shares to increase the number of outstanding shares. Accordingly, the stock price of the company's shares decreases, which maintains the market capitalization before and after the split. In contrast, there are also reverse stock splits that reduce the number of outstanding shares (consolidate). In this case, too, the market cap is maintained as the share price increases following the reverse stock split. Companies often undertake stock splits to improve the liquidity of the common shares and make them more affordable for retail investors. Let's look quickly at the upcoming stock splits for the week. ARCA Biopharma (ABIO) – ARCA Biopharma is now Oruka Therapeutics following the completion of its merger with Oruka on August 29. Oruka is a clinical-stage biopharmaceutical company developing novel treatments for plaque psoriasis, psoriatic arthritis, and other dermatologic and inflammatory indications. On August 23, ARCA's
Show less
Read more
Impact Snapshot
Event Time:
ABIO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABIO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABIO alerts
High impacting ARCA biopharma, Inc. news events
Weekly update
A roundup of the hottest topics
ABIO
News
- ARCA biopharma, Inc. (NASDAQ: ABIO) was upgraded by analysts at StockNews.com to a "sell" rating.MarketBeat
- ARCA biopharma Announces Completion of Merger with Oruka Therapeutics and Implementation of Reverse Stock Split [Yahoo! Finance]Yahoo! Finance
- ARCA biopharma Announces Completion of Merger with Oruka Therapeutics and Implementation of Reverse Stock SplitGlobeNewswire
- ARCA biopharma Provides Update Regarding Special Dividend Amount in Connection with the Proposed Merger with Oruka TherapeuticsGlobeNewswire
- ARCA biopharma Announces 1-for-12 Reverse Stock Split in Connection with the Proposed Merger with Oruka TherapeuticsGlobeNewswire
ABIO
Sec Filings
- 8/30/24 - Form 4
- 8/27/24 - Form SEC
- 8/27/24 - Form SEC
- ABIO's page on the SEC website